<div class="article">
	<h3>Technology Brief -- Cetus Corp.:
   Firm Is Sued by Erbamont
   In Patent-Infringement Case</h3>
	<div class="article-info">
		<ul>
			<li>Author: Author Unknown</li>
			<li>Date: 09/11/90</li>
		</ul>
	</div>
	<p class="article-leader">Cetus Corp. said Erbamont Inc., Stamford, Conn., sued
Cetus, alleging patent infringement.
   Cetus, of Emeryville, Calif., said the suit was filed in
federal court in Cleveland. Cetus, a biotechnology company,
said Erbamont alleged that a Cetus joint venture's sales of
doxorubicin, a widely prescribed chemotherapeutic agent,
violates a patent held by a foreign subsidiary of Erbamont.</p>
	<div class="article-body"><p>Cetus said it is continuing to market the product.
Erbamont officials couldn't be reached for comment.</p>
<p></p></div>
</div>
